Literature DB >> 10690163

Incorporation and washout of orally administered n-3 fatty acid ethyl esters in different plasma lipid fractions.

S D Zuijdgeest-van Leeuwen1, P C Dagnelie, T Rietveld, J W van den Berg, J H Wilson.   

Abstract

The aim of the present study was to quantify the incorporation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) into plasma lipids after oral administration of n-3 fatty acid ethyl esters, since little is known about the rate and pattern of incorporation into plasma lipid fractions. In addition, we aimed to obtain preliminary information regarding EPA half-life, which is needed to establish an optimal dosing schedule. Five healthy volunteers ingested two 8.5 g doses of n-3 fatty acid ethyl esters daily for 7 d, supplying 6.0 g EPA/d and 5.3 g DHA/d. The fatty acid compositions of plasma phospholipids (PL), cholesteryl esters (CE) and triacylglycerols (TAG) were determined during supplementation and during a washout period of 7 d. Half-lives of EPA and DHA were calculated. The proportion of EPA in PL showed a 15-fold increase after 7 d (P < 0.001), while DHA showed a smaller increase (P < 0.01). In CE, EPA also increased (P < 0.05), while DHA did not increase at all. Remarkably, incorporation of DHA into TAG was even higher than that of EPA. Half-life of EPA in PL ranged from 1.63 to 2.31 d (mean 1.97 (SE 0.15) d), whereas mean half-life of EPA in CE was 3.27 (SE 0.56) d. In three subjects, washout of EPA and DHA from TAG seemed to follow a bi-exponential pattern, with a short half-life (< 1 d) in the initial phase and a half-life of several days in the second phase. In conclusion, EPA ethyl esters are rapidly incorporated into plasma lipids, especially into PL. The relatively long half-life of EPA in plasma would permit a dosing schedule with intervals of > or = 12 h in supplementation studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10690163     DOI: 10.1017/s0007114599001737

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  14 in total

1.  A short-term n-3 DPA supplementation study in humans.

Authors:  Eliza Miller; Gunveen Kaur; Amy Larsen; Su Peng Loh; Kaisa Linderborg; Harrison S Weisinger; Giovanni M Turchini; David Cameron-Smith; Andrew J Sinclair
Journal:  Eur J Nutr       Date:  2012-06-23       Impact factor: 5.614

2.  The science behind dietary omega-3 fatty acids.

Authors:  Marc E Surette
Journal:  CMAJ       Date:  2008-01-15       Impact factor: 8.262

3.  Associations Between Preconception Plasma Fatty Acids and Pregnancy Outcomes.

Authors:  Keewan Kim; Richard W Browne; Carrie J Nobles; Rose G Radin; Tiffany L Holland; Ukpebo R Omosigho; Matthew T Connell; Torie C Plowden; Brian D Wilcox; Robert M Silver; Neil J Perkins; Enrique F Schisterman; Christina M Nichols; Daniel L Kuhr; Lindsey A Sjaarda; Sunni L Mumford
Journal:  Epidemiology       Date:  2019-11       Impact factor: 4.822

4.  Complete assessment of whole-body n-3 and n-6 PUFA synthesis-secretion kinetics and DHA turnover in a rodent model.

Authors:  Adam H Metherel; R J Scott Lacombe; Raphaël Chouinard-Watkins; Kathryn E Hopperton; Richard P Bazinet
Journal:  J Lipid Res       Date:  2017-12-11       Impact factor: 5.922

5.  Lipid mediator serum profiles in asthmatics significantly shift following dietary supplementation with omega-3 fatty acids.

Authors:  Susanna L Lundström; Jun Yang; John D Brannan; Jesper Z Haeggström; Bruce D Hammock; Parameswaran Nair; Paul O'Byrne; Sven-Erik Dahlén; Craig E Wheelock
Journal:  Mol Nutr Food Res       Date:  2013-07-04       Impact factor: 5.914

6.  Pharmacokinetics of omega-3 fatty acids in patients with severe sepsis compared with healthy volunteers: A prospective cohort study.

Authors:  Radhika Parikh; Jason H T Bates; Matthew E Poynter; Benjamin T Suratt; Polly E Parsons; C Lawrence Kien; Daren K Heyland; Karen I Crain; Julie Martin; Jayanthi Garudathri; Renee D Stapleton
Journal:  Clin Nutr       Date:  2019-04-09       Impact factor: 7.324

7.  Plasma Phosphatidylethanolamine and Triacylglycerol Fatty Acid Concentrations are Altered in Major Depressive Disorder Patients with Seasonal Pattern.

Authors:  Yurika Otoki; Marie Hennebelle; Anthony J Levitt; Kiyotaka Nakagawa; Walter Swardfager; Ameer Y Taha
Journal:  Lipids       Date:  2017-04-24       Impact factor: 1.880

8.  Eicosapentaenoic acid suppression of systemic inflammatory responses and inverse up-regulation of 15-deoxyΔ(12,14) prostaglandin J2 production.

Authors:  Jillian Davidson; Warren Higgs; Dino Rotondo
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

9.  Treatment with omega-3 fatty acid ethyl-ester alters fatty acid composition of lipoproteins in overweight or obese adults with insulin resistance.

Authors:  Alicia H Augustine; Lisa M Lowenstein; William S Harris; Gregory C Shearer; Robert C Block
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-12-18       Impact factor: 4.006

10.  Short term effects of dietary medium-chain fatty acids and n-3 long-chain polyunsaturated fatty acids on the fat metabolism of healthy volunteers.

Authors:  Christopher Beermann; J Jelinek; T Reinecker; A Hauenschild; G Boehm; H-U Klör
Journal:  Lipids Health Dis       Date:  2003-11-17       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.